Uncovering the Impact of MMP-9 and TIMPs in Diabetic Nephropathy: A Review on Bioflavonoids in Disease Management

Résumé fourni par la source

Abstract: This article provides a thorough analysis of the complex roles played by tissue inhibitors of metalloproteinases (TIMPs) and matrix metalloproteinase-9 (MMP-9) in the development and progression of diabetic nephropathy (DN). Diabetic nephropathy, a notable complication of diabetes, is characterized by a progressive decline in kidney function, prompting a thorough examination of its fundamental molecular pathways. This article presents a comprehensive overview of the function played by MMP-9, a key enzyme in the remodeling of extracellular matrix, in developing tubulointerstitial and glomerular fibrosis, which are critical aspects of renal dysfunction in DN. Simultaneously, the review delves into the regulatory functions of TIMPs, emphasizing their crucial role in maintaining the delicate balance between matrix degradation and repair. The abnormal regulation of the MMP-9/TIMP axis is explored as a pivotal factor contributing to increased vascular permeability, inflammation, and structural alterations within the renal microenvironment. By synthesizing current research findings, the purpose of this review was to unravel the complex molecular interplay between MMP-9 and TIMPs in diabetic nephropathy. The insights derived from this comprehensive analysis hold promise for identifying potential therapeutic targets that could mitigate renal damage, arrest disease progression, and enhance clinical outcomes for individuals grappling with diabetic nephropathy. Finally, it concludes by emphasizing the necessity for additional research to validate these findings and facilitate the translation of this knowledge into targeted therapeutic interventions for improved management of diabetic nephropathy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.